Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Sagar Agarwal, Ramola Sane, Jose L. Gallardo, John R. Ohlfest and William F. Elmquist
Journal of Pharmacology and Experimental Therapeutics July 2010, 334 (1) 147-155; DOI: https://doi.org/10.1124/jpet.110.167601
Sagar Agarwal
Ramola Sane
Jose L. Gallardo
John R. Ohlfest

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Sagar Agarwal, Ramola Sane, Jose L. Gallardo, John R. Ohlfest and William F. Elmquist
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 147-155; DOI: https://doi.org/10.1124/jpet.110.167601
Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Sagar Agarwal, Ramola Sane, Jose L. Gallardo, John R. Ohlfest and William F. Elmquist
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 147-155; DOI: https://doi.org/10.1124/jpet.110.167601
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement